Andere talen Sona Nanotech Inc.

Aandelen

SONA

CA83541C1059

Beurs gesloten - Canadian Securities Exchange Andere beurzen 21:59:59 25-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,26 ^CAD	0,00%		-16,13%	+8,33%

21/05	Sona Nanotech benoemt Chief Medical Officer, dient voorlopig conjugatiepatent in	MT
21/05	Sona Nanotech Inc. Benoemt Dr. Carman Giacomantonio Md, Msc., Frcsc tot Chief Medical Officer	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Sona's Therapy Shows Significant Preclinical Efficacy in Second Cancer	20/06
Sona Nanotech Appoints Chief Medical Officer, Files Provisional Conjugation Patent	21/05
Sona Appoints Chief Medical Officer and Files Provisional Conjugation Patent	21/05
Sona Nanotech Inc. Appoints Dr. Carman Giacomantonio Md, Msc., Frcsc as Chief Medical Officer	21/05
Sona Nanotech Inc. Files Provisional Conjugation Patent	21/05
Sona Nanotech Inc. Announces Further Results from the Triple Negative Breast Cancer Mice Model Portion of Its Current Research Study At Dalhousie University	29/04
Sona's Cancer Therapy Creates a Systemic Immune Response in Murine Breast Cancer Model	29/04
Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study	15/04
Sona Nanotech Provides Interim Results of Dalhousie Study	12/04
Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study	12/04
Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study	12/04
Sona Nanotech Secures Grant Funding to Support Intellectual Property Strategy and Development	08/04
Sona Nanotech Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	29/03
Sona Nanotech Updates on Dalhousie Efficacy Study and New NCL Results	25/03
Sona Nanotech Inc. Appoints Dr. Carman Giacomantonio to its Advisory Board	18/03
Sona Nanotech Inc. Announces Filing of Provisional Patent Application	18/03
Sona Nanotech Announces Filing of Provisional Patent Application	18/03
Sona Nanotech Grants Options	01/03
Sona Nanotech Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	27/02
Sona Nanotech Inc. Announces Retirement of Michael Gross from the Board of Directors	10/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Sona Nanotech Inc.

Aandelen

SONA

CA83541C1059

Andere talen

Filters